Device Cmf & Thoracic

Medline

Payments companies reported to CMS as associated with Medline. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6.4Massociated payments (2023-2025)

700clinicians with associated payments

5companies reporting

By year

2023 $11K

2024 $4.4M

2025 $2.0M

Payments reported as associated with Medline, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pediatric Surgery $2.6M

Orthopaedic Surgery $1.6M

Foot & Ankle Surgery $1.2M

Thoracic Surgery (Cardiothoracic Vascular Surgery) $465K

Foot and Ankle Surgery $302K

Podiatrist $85K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Medline

These are the largest totals companies reported as associated with Medline. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Donald Nuss	Norfolk, VA	Pediatric Surgery	$1,575,643.35
Rull James Toussaint	Gainesville, FL	Orthopaedic Surgery	$484,808.00
Robert Obermeyer	Norfolk, VA	Pediatric Surgery	$478,541.48
Robert Kelly	Norfolk, VA	Pediatric Surgery	$475,496.48
Dawn Jaroszewski	Phoenix, AZ	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$461,245.92
Mark Prissel	Worthington, OH	Foot & Ankle Surgery	$445,665.96
Gregory Berlet	Worthington, OH	Orthopaedic Surgery	$351,122.00
John Ellington	Charlotte, NC	Orthopaedic Surgery	$273,915.74
Matthew Sorensen	Algonquin, IL	Foot & Ankle Surgery	$247,470.24
John Lewis	Louisville, KY	Orthopaedic Surgery	$143,421.92

Prescribed Medline?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.